28.05.2024 - BRISBANE, Calif., May 28, 2024 (GLOBE NEWSWIRE) - Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological ... Seite 1

Related Keywords

Brisbane , Queensland , Australia , Marshall Fordyce , Drug Administration , Vera Therapeutics Inc , Nasdaq , Breakthrough Therapy Designation , Therapy Designation ,